Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Am J Transplant. 2016 Mar 31;16(8):2453–2462. doi: 10.1111/ajt.13758

Table 4.

Heterogeneity across unadjusted and both adjusted models.

ISx Regimen (Ref: Tac+ MPA/AZA+Pred) Proportion of variance in hierarchical model explained by center characteristics (Unadjusted) MOR Proportion of variance in hierarchical model explained by center, adjusted for donor/recipient factors MOR Proportion of variance in model explained by donor/recipient characteristics
Tac+MPA/AZA 0.30 3.11 0.30 3.14 0.05
Tac alone, Tac+Pred 0.16 2.10 0.15 2.08 0.04
SRL-based 0.40 4.16 0.42 4.42 0.04
CSA-based 0.46 5.02 0.47 5.15 0.06
Other 0.14 2.03 0.15 2.06 0.02

Proportion of variance in hierarchical model is equal to the Intraclass Correlation Coefficient, ICC.

MOR, Median Odds Ratio

CSA, Cyclosporine; ISx, immunosuppression; MPA/AZA, mycophenolate acid; Pred, prednisone; Tac, tacrolimus.